Exelixis, Inc.
EXEL · NASDAQ
1/3/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | 2.62 | -1.29 | 0.24 |
| FCF Yield | 6.43% | 2.23% | 4.35% | 5.85% |
| EV / EBITDA | 13.71 | 38.45 | 21.79 | 17.18 |
| Quality | ||||
| ROIC | 18.00% | 5.41% | 5.70% | 9.88% |
| Gross Margin | 96.49% | 96.04% | 96.41% | 96.32% |
| Cash Conversion Ratio | 1.34 | 1.60 | 1.99 | 1.73 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.42% | 8.45% | 17.72% | 14.03% |
| Free Cash Flow Growth | 272.04% | -24.00% | -33.40% | 88.42% |
| Safety | ||||
| Net Debt / EBITDA | -0.00 | -0.37 | -1.40 | -1.98 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.40 | 4.19 | 1.74 | 1.92 |
| Cash Conversion Cycle | -28.50 | -35.39 | 52.64 | 94.23 |